Breast Cancer : the Journal of the Japanese Breast Cancer Society
Overview
Breast Cancer: The Journal of the Japanese Breast Cancer Society is a reputable scientific journal dedicated to advancing knowledge and understanding of breast cancer. It publishes high-quality research articles, reviews, and case studies, covering various aspects of breast cancer, including prevention, diagnosis, treatment, and survivorship. With a focus on the Japanese perspective, this journal serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in breast cancer care and research.
Details
Details
Metrics
Metrics
h-index / Ranks: 5503
66
SJR / Ranks: 3463
1054
CiteScore / Ranks: 4260
5.60
JIF / Ranks: 2264
4.0
Recent Articles
1.
Dong C, Sun Y, Xu X, Li H, Song X, Wei W, et al.
Breast Cancer
. 2025 Mar;
PMID: 40029493
Background: Poor prognosis of triple-negative breast cancer (TNBC) is owing to its intrinsic heterogeneity and lack of targeted therapies. Emerging evidence has characterized that targeting c-Myc might be a promising...
2.
Behrens A, Huebner H, Haberle L, Stamminger M, Zint D, Heindl F, et al.
Breast Cancer
. 2025 Mar;
PMID: 40025401
No abstract available.
3.
Wu Q, He J, Herrler T, Yu B, Zhou Q, Zheng D, et al.
Breast Cancer
. 2025 Feb;
PMID: 40019720
Background: Adipose-derived stem cells (ADSCs)-assisted fat grafting has emerged as a widely used procedure for breast reconstruction post mastectomy and for aesthetic augmentation. Given the limited cases of breast cancer...
4.
Wu S, Chen V, Hsu Y, Tzang B, Stewart R, Lin C
Breast Cancer
. 2025 Feb;
PMID: 39998810
Background: This study investigated fluctuations in levels of chosen cytokines among patients with breast cancer before to after chemotherapy. Contemporaneous changes in cognitive function were examined. Methods: Adult patients with...
5.
Natori K, Igeta M, Morimoto T, Nagahashi M, Akashi-Tanaka S, Daimon T, et al.
Breast Cancer
. 2025 Feb;
PMID: 39979692
Background: Immune and inflammatory blood parameters have been reported as biomarkers for treatment efficacy. This study aimed to establish a predictive model that includes blood parameters for patients with metastatic...
6.
Ando Y, Masuda T, Hayashi N, Kosai K, Shibuta S, Ono Y, et al.
Breast Cancer
. 2025 Feb;
PMID: 39979691
Background: The single-nucleotide polymorphism rs6507583 at the promoter of SET-binding protein 1 (SETBP1) was implicated in estrogen receptor (ER)-positive breast carcinogenesis. Here, we evaluated the clinical and biological relevance of...
7.
Kawashima K, Narui K, Nishikawa A, Sasamoto M, Oshi M, Adachi S, et al.
Breast Cancer
. 2025 Feb;
PMID: 39976837
Background: The MonarchE trial demonstrated the additional benefit of abemaciclib as an adjuvant endocrine therapy for high-risk patients with hormone receptor (HR)-positive HER2-negative breast cancer. Meanwhile, the ACOSOG Z0011 trial...
8.
Kim S, Oh J, Kim Y, Kim J, Lee W, Chang J, et al.
Breast Cancer
. 2025 Feb;
PMID: 39964591
Background: Early prediction and management are crucial for treating breast cancer-related lymphedema (BCRL), yet the risk factors remain poorly understood. This study aims to explore the relationship between postoperative changes...
9.
Nishimura R, Sagara Y, Mitsueda R, Taira T, Miyaki T, Kanemitsu S, et al.
Breast Cancer
. 2025 Feb;
PMID: 39964590
Background: Recurrent breast cancer (BC) has poor prognosis. To ascertain the survival time after recurrence (STR) is necessary for improving QOL and for selecting appropriate treatment. An investigation was conducted...
10.